A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: A histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases

Human Pathology

Volumn 43, Issue 5, 2012, Pages 726-736

  Petersson, Fredrik ^a,b   Vaněček, Tomáš ^a   Michal, Michal ^a   Martignoni, Guido ^c   Brunelli, Matteo ^c   Halbhuber, Zbyněk ^d   Spagnolo, Dominic ^e   Kuroda, Naoto ^f   Yang, Ximing ^g   Cabrero, Isabel Alvarado ^h   Hora, Milan ^a   Branžovský, Jindřich ^a   Trivunic, Sandra ⁱ   Kacerovská, Denisa ^a   Steiner, Petr ^a   Hes, Ondřej ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c UNIVERSITY OF VERONA   (Italy)

^d Microarray Facility   (Czech Republic)

^e PATHWEST LABORATORY MEDICINE   (Australia)

^f KOCHI RED CROSS HOSPITAL   (Japan)

^g NORTHWESTERN UNIVERSITY   (United States)

^h Centro Medico Mexico City   (Mexico)

ⁱ University Novi Sad   (Serbia)

Author keywords

Chromosomal changes; Immunohistochemistry; Kidney; Morphology; TFEB; Translocation carcinoma; Translocation t(6; 11)

Indexed keywords

CATHEPSIN K; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN; MELAN A; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOCLONAL ANTIBODY HMB 45; MONOPHENOL MONOOXYGENASE; VIMENTIN; VON HIPPEL LINDAU PROTEIN;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME TRANSLOCATION 6; CLINICAL FEATURE; CYTOGENETICS; ECHOGRAPHY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE MUTATION; HEMATURIA; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MALE; METHYLATION; MOLECULAR GENETICS; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; ROSETTE FORMING CELL; ULTRASTRUCTURE;

ADULT; CARCINOMA, RENAL CELL; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; HUMANS; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MELANOMA-SPECIFIC ANTIGENS; METHYLATION; MIDDLE AGED; PROMOTER REGIONS, GENETIC; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84859901585     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.07.001     Document Type: Article

References (31)

1. Argani P, Ladanyi M. Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. Tumours of the urinary system and male genital organs. Lyon, France: IARC Press; 2004. p. 37-8.
2. Argani P, Hawkins A, Griffin CA, et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1; q12) chromosome translocation. Am J Pathol 2001;158:2089-96. (Pubitemid 32545194)
3. Franzini A, Picozzi SC, Politi PL, et al. Case of renal cancer with TFE3 gene fusion in an elderly man. Clinical, radiological and surgical findings. Urol Int 2007;78:179-81. (Pubitemid 46239141)
4. Dijkhuizen T, van den Berg E, Störkel S, van Kessel AG, Janssen B, de Jong B. Two cases of renal cell carcinoma, clear cell type, revealing a t(6;11)(p21;q13). Cancer Genet Cytogenet 1996;91:141.
5. van Asseldonk M, Schepens M, de Bruijn D, Janssen B, Merkx G, Geurts van Kessel A. Construction of a 350-kb sequence-ready 11q13 cosmid contig encompassing the markers D11S4933 and D11S546: mapping of 11 genes and 3 tumor-associated translocation breakpoints. Genomics 2000;66:35-42. (Pubitemid 30347169)
6. Davis IJ, Hsi BL, Arroyo JD, et al. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci U S A 2003;100:6051-6. (Pubitemid 36576929)
7. Kuiper RP, Schepens M, Thijssen J, et al. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum Mol Genet 2003;12:1661-9. (Pubitemid 36896659)
8. Pecciarini L, Cangi MG, Lo Cunsolo C, et al. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient. Genes Chromosomes Cancer 2007;46:419-26. (Pubitemid 46449244)
9. Hora M, Hes O, Urge T, Eret V, Klecka J, Michal M. A distinctive translocation carcinoma of the kidney ["rosette-like forming," t(6;11), HMB45-positive renal tumor]. Int Urol Nephrol 2009;41:553-7.
10. Suarez-Vilela D, Izquierdo-Garcia F, Mendez-Alvarez JR, Miguelez-Garcia E, Dominguez-Iglesias F. Renal translocation carcinoma with expression of TFEB: presentation of a case with distinctive histological and immunohistochemical features. Int J Surg Pathol 2011;19: 506-9.
11. Zhan HQ, Wang CF, Zhu XZ, Xu XL. Renal cell carcinoma with t(6;11) translocation: a patient case with a novel Alpha-TFEB fusion point. J Clin Oncol 2010;28:e709-13.
12. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-317. (Pubitemid 38072572)
13. Antonescu CR, Kawai A, Leung DH, et al. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol 2000;9:1-8. (Pubitemid 30131955)
14. Gaffney R, Chakerian A, O'Connell JX, et al. Novel fluorescent ligase detection reaction and flow cytometric analysis of SYT-SSX fusions in synovial sarcoma. J Mol Diagn 2003;5:127-35. (Pubitemid 36553433)
15. Tsuji S, Hisaoka M, Morimitsu Y, et al. Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Am J Pathol 1998;153:1807-12. (Pubitemid 28550668)
16. Workman C, Jensen LJ, Jarmer H, et al. A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol 2002;3 [research0048. Epub 2002].
17. Larson PS, de las Morenas A, Bennett SR, Cupples LA, Rosenberg CL. Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas. Am J Pathol 2002;161: 283-90. (Pubitemid 34760794)
18. Hes O, Michal M, Sima R, et al. Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical and genetic features. Virchows Arch 2008;452:285-93.
19. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6. (Pubitemid 26296693)
20. Argani P, Lae M, Hutchinson B, et al. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol 2005;29:230-40. (Pubitemid 40170642)
21. Kacerovska D, Michal M, Nemcova J, et al. Crystal-deficient alveolar soft-part sarcoma with cutaneous involvement: a case report. Am J Dermatopathol 2009;31:272-7.
22. Martignoni G, Tardanico R, Pea M, et al. C D. t6;11 renal cell tumor. A clinicopathological study of two cases in adults. Modern Pathol 2005;18(Suppl 1):155A.
23. Ross H, Argani P. Xp11 translocation renal cell carcinoma. Pathology 2010;42:369-73.
24. Argani P, Olgac S, Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol 2007;31:1149-60. (Pubitemid 47207116)
25. Swartz MA, Karth J, Schneider DT, Rodriguez R, Beckwith JB, Perlman EJ. Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology 2002;60:1083-9. (Pubitemid 35447572)
26. Nese N, Martignoni G, Fletcher CD, et al. Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification. Am J Surg Pathol 2011;35:161-76.
27. Martignoni G, Pea M, Bonetti F, Brunelli M, Eble JN. Oncocytoma-like angiomyolipoma. A clinicopathologic and immunohistochemical study of 2 cases. Arch Pathol Lab Med 2002;126:610-2. (Pubitemid 34477961)
28. Martignoni G, Pea M, Gobbo S, et al. Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol 2009;22:1016-22.
29. Kamishima T, Fukuda T, Emura I, Tanigawa T, Naito M. Pigmented renal cell carcinoma. Am J Surg Pathol 1995;19:350-6.
30. Fukuda T, Kamishima T, Emura I, Takastuka H, Suzuki T. Pigmented renal cell carcinoma: accumulation of abnormal lysosomal granules. Histopathology 1997;31:38-46. (Pubitemid 27314504)
31. Lei JY, Middleton LP, Guo XD, et al. Pigmented renal clear cell carcinoma with melanocytic differentiation. HUM PATHOL 2001;32: 233-6. (Pubitemid 32193724)